Anticoagulation Manager Training Day Plan

Size: px
Start display at page:

Download "Anticoagulation Manager Training Day Plan"

Transcription

1 Anticoagulation Manager Training Day Plan Versioning Author: Debbie Cuthbert/Emma Stubbs Reviewer(s): Debbie Cuthbert, Jim Holden Date Version Contents 22/10/ Initial draft day plan. 31/10/ Guidance timing added 1

2 Vision+ Anticoagulation Training Day Plan Overview As you may be aware, Warfarin is the main Anticoagulation treatment for the prevention of stroke and thromboembolic conditions in certain patients with Atrial Fibrillation (AF). Recently published NICE (National Institute for Health and Clinical Excellence) draft guidelines permit the use of new oral anticoagulation drugs (NOACs), along with other risk factors their use is likely to be based on INR (International Normalised Ratio) control. Vision+ Anticoagulation Manager contains tools for managing all aspects of anticoagulation regardless of the patient's drug regime. It includes Adverse Event Reporting, advice on Dosing regimes and presents supporting materials for structured Education and Reviews. When you select a patient in Consultation Manager an alert window will warn if the patient is missing essential anticoagulation information that will assist in the management of their care. There is also an easy to use Clinical Template where you can quickly record relevant information. In addition, a suite of reports will capture data and provide a comprehensive reporting tool. In all Anticoagulation Manager comprises: Alerts for missing/due data Anticoagulation Templates which include:anticoagulation Therapy management screen Warfarin management and dosing tool Diagnosis Indication screen INR monitoring screen Management screen for New Oral Anticoagulant Drugs Other Assessment screen showing other factors that may affect the patient's anticoagulant treatment Reporting facility which allows you to work on patient lists or create a mail merge Who should attend the training? Practice Manager, Clinicians, Relevant Administrative Staff General Prerequisites Understanding of existing practice protocols for anticoagulation management. 2

3 Aims and Objectives Aims The aim of this training day is to demonstrate how to use and implement the new Vision+ Anticoagulation Manager tool. Objectives By the end of the day the training delegates will be able to: Download and Maintain the Anticoagulation tool. Implement the Vision Anticoagulation Manager according to their own practice protocols. Record and monitor anticoagulation patients in consultations and during administrative work using the templates. Record and maintain anticoagulation dosage and realise that weekly dosage, not daily dosage is displayed in the patient journal (important!). Change practice and patient settings as required. Create Vision+ reports on Anticoagulation data. Note Timings below are approximate and can be adjusted to suit practice preferences. 3

4 Course Content Timings Aimed at Detail Up to 40 mins Practice Manager/I T administra tor Explanation of what Anticoagulation consists of e.g. template, reports, Warfarin monitor Review practice protocols with the PM/IT Manager Ask how they currently deal with INR monitoring Review paper based systems Make notes of who does what e.g. INR result comes in, given to gp, GP records INR and works out daily dose, staff phone patient Download the template and explain how to use Download Web files Give the IT/PM an overview of the Warfarin tool (consider who will do what) Discuss INR history Five weekly dosing histories and how to add to the dosing history screen Demonstrate how to link to a Diagnostic indication Discuss how the dosing tool screen works Demonstrated how this information is embedded in the Anticoagulation Template (show the PM/IT Manager to get a feel for what the clinicians will use). 4

5 1 hour Clinical Staff Start the training on the Warfarin Monitor option within Anticoagulation Manager (as this is the quickest and simplest way to record data) Discuss INR history (shows the last 5). Five weekly dosing histories and how to add to the dosing history screen. Demonstrate how they can change the screen layout. Look at Trends. Print options. Demonstrate how to link to a Diagnostic indication Discuss how the dosing tool screen works add an INR to a dummy patient and explain. Round up and Round down, Use, Clear, Missed days, recalls. Explain there is also an Anticoagulation template which includes this but can be used for additional information. 30 mins Practice Manager/I T Administra tor Explain Practice Settings point out recalls Discuss Patient Settings Provide an overview of Anticoagulation Template including Dosing tool, care pathways, print options Look at the Practice Reports, this includes Anticoagulation manager and Warfarin monitor reports Discuss how to combine alerts if this option is enabled 30 mins Reception (ir relevant) Show reception how to view the Daily dose using the Warfarin Dose screen. Emphasise they should check date, INR, daily dose and next recall Point out that a weekly dose is displayed in the journal and not a daily dose 5

6 Related Materials Anticoagulation Getting Started Guide ager%20-%20getting%20started.pdf Anticoagulation Full User Guide ager.pdf Anticoagulation Marketing (Including overview video) elearning TBC 6

West Midlands Strategic Clinical Network & Senate Improving the detection and management of Atrial Fibrillation in Primary Care

West Midlands Strategic Clinical Network & Senate Improving the detection and management of Atrial Fibrillation in Primary Care West Midlands Strategic Clinical Network & Senate Improving the detection and management of Atrial Fibrillation in Primary Care Good Practice Guide Improving the detection and management of Atrial Fibrillation

More information

Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies

Linda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and

More information

Setting up the NOAC Service & Taking it to Primary Care

Setting up the NOAC Service & Taking it to Primary Care Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015 Buckinghamshire Health Care NHS Trust Quiz 1. What is the most serious side

More information

Commissioning effective anticoagulation services for the future: A resource pack for commissioners

Commissioning effective anticoagulation services for the future: A resource pack for commissioners Commissioning effective anticoagulation services for the future: A resource pack for commissioners The development of this commissioning toolkit was supported by Bayer HealthCare. Bayer HealthCare paid

More information

Quality Standards for Enhanced Primary Care Services. Version 1.2

Quality Standards for Enhanced Primary Care Services. Version 1.2 Quality Standards for Enhanced Primary Care Services Version 1.2 September 2014 8831 September 2014 West Midlands Quality Review Service These Quality Standards may be reproduced and used freely by NHS

More information

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )

Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( ) Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted

More information

ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL

ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL CAN REAL WORLD/PUBLICALLY AVAILABLE DATA COUPLED WITH TTR DATA HELP THE NHS STOP STROKES? Andrzei Orlowski -Programme Development Lead for Health and Implementation

More information

MANAGING THE INR CLINIC : IJN EXPERIENCE

MANAGING THE INR CLINIC : IJN EXPERIENCE MANAGING THE INR CLINIC : IJN EXPERIENCE Anticoagulation Workshop 21 st August 2015 KAMALESWARY ARUMUGAM PRINCIPAL PHARMACIST LEE LEE HO1 NURSE MENTOR, INR CLINIC HISTORY & OVERVIEW OF THE INR CLINIC HISTORY

More information

ANTI-COAGULATION MONITORING

ANTI-COAGULATION MONITORING ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This

More information

AHSN AF Programme The Results So Far. Kate Mackay AF Programme Manager

AHSN AF Programme The Results So Far. Kate Mackay AF Programme Manager AHSN AF Programme The Results So Far Kate Mackay AF Programme Manager Atrial Fibrillation Programme Aim To decrease the number of AF-related strokes by: Decreasing the prevalence gap and finding the missing

More information

Digital INR Monitoring A model of remote INR testing. Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT

Digital INR Monitoring A model of remote INR testing. Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT Digital INR Monitoring A model of remote INR testing Ian Dove, Tracy Murphy, Jeannie Hardy County Durham and Darlington NHS FT About NHS Health Call NHS Health Call is a digital health partnership between

More information

Initiation of Warfarin for patients not registered with Provider Practice

Initiation of Warfarin for patients not registered with Provider Practice Initiation of Warfarin for patients not registered with Provider Practice 2017-18 1. Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called Initiation of Warfarin

More information

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly

Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Universal Offer Service Anticoagulation - Warfarin Clinical Lead Dr Kevan Ritchie Commissioner Camden Clinical Commissioning Group Reporting Mechanism/Frequency Remotely/Quarterly Payment Frequency Quarterly

More information

Warfarin or NOACs Lessons from real-life data in different countries. Giuseppe Patti Campus Bio-Medico University of Rome

Warfarin or NOACs Lessons from real-life data in different countries. Giuseppe Patti Campus Bio-Medico University of Rome Warfarin or NOACs Lessons from real-life data in different countries Giuseppe Patti Campus Bio-Medico University of Rome Efficacy (CRTs) Effectiveness (Real-world data) Objective Setting Efficient and

More information

An Evaluation of the BVH Initiation of warfarin for DVT. Sean O Brien Specialist Anticoagulation BMS Oct 2015

An Evaluation of the BVH Initiation of warfarin for DVT. Sean O Brien Specialist Anticoagulation BMS Oct 2015 An Evaluation of the BVH Initiation of warfarin for DVT Sean O Brien Specialist Anticoagulation BMS Oct 2015 Service Provision ADAS is a Consultant led service managed by the Pathology Directorate. Provides

More information

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS

Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the

More information

Storyboard Submission NHS Wales Awards Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated INRs

Storyboard Submission NHS Wales Awards Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated INRs Storyboard Submission 1. Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated 2. Brief Outline of Context As part of the 1000 Lives Plus initiative, ward pharmacists throughout ABHB

More information

Community Clinics Policy and Procedure Manual C - 9 WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL

Community Clinics Policy and Procedure Manual C - 9 WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL Community Clinics Policy and Procedure Manual C - 9 SUBJECT: WARFARIN ADJUSTMENT PROTOCOL SUBJECT: WARFARIN ADJUSTMENT PROTOCOL APPROVED BY: VP Acute & Long Term Care & COO (South) EFFECTIVE DATE: 2007

More information

DANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017]

DANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017] DANNOAC-AF synopsis. [Version 7.9v: 5th of April 2017] A quality of care assessment comparing safety and efficacy of edoxaban, apixaban, rivaroxaban and dabigatran for oral anticoagulation in patients

More information

Improvement Activities for ACI Bonus Measures

Improvement Activities for ACI Bonus Measures Improvement Activity Performance Category Subcategory Expanded Practice Activity Name Activity Improvement Activity Performance Category Weight Provide 24/7 access to eligible clinicians or groups, who

More information

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector

Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes

More information

Reducing Warfarin ADR s with a Nurse Led Anticoagulation Clinic: A New Model of Patient Care

Reducing Warfarin ADR s with a Nurse Led Anticoagulation Clinic: A New Model of Patient Care Baptist Health South Florida Scholarly Commons @ Baptist Health South Florida All Publications 6-16-2017 Reducing Warfarin ADR s with a Nurse Led Anticoagulation Clinic: A New Model of Patient Care Michael

More information

Support for Anticoagulation UK with this project has been provided by MHP Health, whose services were paid for by Bayer. Bayer has reviewed the

Support for Anticoagulation UK with this project has been provided by MHP Health, whose services were paid for by Bayer. Bayer has reviewed the Support for Anticoagulation UK with this project has been provided by MHP Health, whose services were paid for by Bayer. Bayer has reviewed the contents of the report to ensure compliance with the ABPI

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications 1 Introduction Anticoagulants are medicines which slow down the blood clotting process and are used to support the prevention of clot development. They

More information

Advancing Care Information Measures

Advancing Care Information Measures Participants: Advancing Care Information Measures In 2017, Advancing Care Information (ACI) measure reporting is optional for Nurse Practitioners, Physician Assistants, Clinical Nurse Specialists, CRNAs,

More information

Service Specification

Service Specification Service Specification Level 4 Anticoagulation Management Release: Final Date: 1/1/11 Author: Suzanne Pickering Primary Care Commissioning Manager NHS Derbyshire County Owner: Jackie Pendleton Assistant

More information

The pathway highlights a clear strategy for managing these patients which includes the following:

The pathway highlights a clear strategy for managing these patients which includes the following: James Cook University Hospital Streamlining the pathway for patients identified in surgical pre admission clinics (PAC) with previously undetected atrial fibrillation. Why was this project implemented?

More information

War on Warfarin: Integrating DOACs into your Anticoagulation Service

War on Warfarin: Integrating DOACs into your Anticoagulation Service War on Warfarin: Integrating DOACs into your Anticoagulation Service David DeiCicchi, Pharm.D, CACP Brigham and Women s Hospital September 30 th, 2016 Disclosures I have no financial conflict of interest

More information

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved

Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS. Approved Document ref. no: Trust Policy and Procedure PP(16)238 MANAGEMENT OF ADULT PATIENTS TREATED WITH ORAL ANTICOAGULANTS For use in: For use by: For use for: Document owner: Status: West Suffolk NHS Foundation

More information

CLINICAL AUDIT. The Safe and Effective Use of Warfarin

CLINICAL AUDIT. The Safe and Effective Use of Warfarin CLINICAL AUDIT The Safe and Effective Use of Warfarin Valid to May 2019 bpac nz better medicin e Background Warfarin is the medicine most frequently associated with adverse drug reactions in New Zealand.

More information

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative. This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document

More information

Myname is Katie Kok. I am from the US here in Illinois actually. I just want to say what a

Myname is Katie Kok. I am from the US here in Illinois actually. I just want to say what a Myname is Katie Kok. I am from the US here in Illinois actually. I just want to say what a privilege it is to be presenting here today. Thank you so much for having me. I will be presenting on Patient

More information

Patient Preference and Patient Empowerment. Inga Drossart, German Heart Foundation

Patient Preference and Patient Empowerment. Inga Drossart, German Heart Foundation Patient Preference and Patient Empowerment Inga Drossart, German Heart Foundation Overview 1. German Heart Foundation & its medical consultation service 2. Patients problems/concerns related to NOACs 3.

More information

Consent for the Vulnerable Adult

Consent for the Vulnerable Adult Consent for the Vulnerable Adult Mental Capacity Act Emma Young Divisional Research Lead - Medicine Key Points What is consent and what is a vulnerable adult Outline the main points from the Mental Capacity

More information

nicheprogram.org 2015 Annual NICHE Conference Innovation Through Leadership 1 Background Background

nicheprogram.org 2015 Annual NICHE Conference Innovation Through Leadership 1 Background Background Keeping Our Patients Safe with Patient Education for Anticoagulation Therapy NICHE Conference Jean-Marie Nacer MSN, RN April 16, 2015 Background September of 2008: The Joint Commission issued a Sentinel

More information

Prescribing Quality Review Scheme (PQRS) 2016/17

Prescribing Quality Review Scheme (PQRS) 2016/17 Introduction: The Prescribing Quality Review Scheme (PQRS) has been designed to reflect the four key principles of medicines optimisation: Understanding and improving patient experience. Evidence based

More information

ANTICOAGULATION CLINIC

ANTICOAGULATION CLINIC ANTICOAGULATION CLINIC COMMUNITY MEMORIAL HOSPITAL AND CLINIC BETTY MEIGHAN, RN, BSN SUMNER, IOWA PROGRAM INITIATION Provider request for patient benefit Time factor for physicians in office Significant

More information

Diagnostics Assessment Report (DAR) - Comments

Diagnostics Assessment Report (DAR) - Comments Diagnostics Assessment Report (DAR) - s Bradford District CCG 1. 1.1 Whilst the views of stakeholders wrt to NOACs varies widely, it is a fact that they have an important place in the pathway of care So

More information

Accreditation Program: Long Term Care

Accreditation Program: Long Term Care ccreditation Program: Long Term are National Patient Safety Goals indicates scoring category ; indicates scoring category ; indicates situational decision rules apply; indicates 2009 The Joint ommission

More information

The Role of the Arrhythmia Nurse

The Role of the Arrhythmia Nurse The Role of the Arrhythmia Nurse RACHEAL JAMES BHF SUPPORTED ARRHYTHMIA NURSE SPECIALIST UHW The Role of the Arrhythmia Nurse Specialist It is now widely recognised that the skills and expertise that nurses

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA) Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology

More information

South East London Area Prescribing Committee (APC) 9 October at Lower Marsh. Final minutes

South East London Area Prescribing Committee (APC) 9 October at Lower Marsh. Final minutes South East London Area Prescribing Committee (APC) 9 October at Lower Marsh Final minutes 1. Welcome, Introductions and Apologies received. 2. Conflicts of Interest declarations The Chair requested any

More information

Drug Therapy Management

Drug Therapy Management 4/17 Welcome to the Centers of Excellence Assessment Becoming an Anticoagulation Center of Excellence gives your service the chance to work as a multidisciplinary team to evaluate your current safety practices

More information

Promoting Interoperability Measures

Promoting Interoperability Measures Promoting Interoperability Measures Previously known as Advancing Care Information for 2017 and Meaningful Use from 2011-2016 Participants: In 2018, promoting interoperability measure reporting (PI) is

More information

ANTICOAGULATION THERAPY MANAGEMENT SOFTWARE

ANTICOAGULATION THERAPY MANAGEMENT SOFTWARE ANTICOAGULATION THERAPY MANAGEMENT SOFTWARE PROCEEDINGS OF THE 20th USER GROUP MEETING 8th/9th October 2012 BETTER CARE FOR LESS EFFORT FROM THE COMPANY THAT REALLY CARES Page 2 Table of Contents Chairman

More information

Pan-London AF Primary Care Programme Launch Event. 6 th June 2016 Data pack NHS Havering CCG

Pan-London AF Primary Care Programme Launch Event. 6 th June 2016 Data pack NHS Havering CCG Pan-London AF Primary Care Programme Launch Event 6 th June 2016 Data pack NHS Havering CCG A simplified view of the AF Pathway Detect (Detect) Protect Correct Perfect Risk stratification Cross correlation

More information

Research Article A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting

Research Article A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting International Family Medicine, Article ID 691454, 4 pages http://dx.doi.org/10.1155/2013/691454 Research Article A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting

More information

Advancing Care Information Performance Category Fact Sheet

Advancing Care Information Performance Category Fact Sheet Fact Sheet The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) replaced three quality programs (the Medicare Electronic Health Record (EHR) Incentive program, the Physician Quality Reporting

More information

WOLVERHAMPTON CCG. Governing Body Meeting 8 April 2014

WOLVERHAMPTON CCG. Governing Body Meeting 8 April 2014 WOLVERHAMPTON CCG Governing Body Meeting ` Agenda item:12 TITLE OF REPORT: REPORT PRESENTED BY: Commissioning Committee Summary Dr Kamran Ahmed Title of Report: Update from the Commissioning Committee

More information

Promoting Interoperability Performance Category Fact Sheet

Promoting Interoperability Performance Category Fact Sheet Promoting Interoperability Fact Sheet Health Services Advisory Group (HSAG) provides this eight-page fact sheet to help providers with understanding Activities that are eligible for the Promoting Interoperability

More information

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs HEALTH SERVICES RESEARCH FUND HEALTH CARE AND PROMOTION FUND Comparison of a clinical pharmacist managed anticoagulation service with routine medical care: impact on clinical outcomes and health care costs

More information

CASE STUDIES. Martin Cassidy Yassir Javaid. Wednesday 16 th March 2016

CASE STUDIES. Martin Cassidy Yassir Javaid. Wednesday 16 th March 2016 CASE STUDIES Martin Cassidy Yassir Javaid Wednesday 16 th March 2016 Case Study 1 Male Aged 44 Family History of stroke due to AF How did you first come aware that your blood pressure was high? What happened

More information

Pharmacist prescribing within an integrated health system in Washington

Pharmacist prescribing within an integrated health system in Washington Pharmacist prescribing within an integrated health system in Washington Roger Woolf, Pharm.D., Virginia Mason Medical Center, Seattle, WA. Amanda Locke, Pharm.D., BCACP, Virginia Mason Medical Center,

More information

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients Oxfordshire Anticoagulation Service Important information about anticoagulation with vitamin K antagonists Information for patients Page 2 Your information Name:... Address:......... or patient stickie

More information

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing

NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix

More information

Request for information under the Freedom of Information Act

Request for information under the Freedom of Information Act Request for information under the Freedom of Information Act - 7402 Thank you for your email dated 6 July 2017 requesting information regarding patients diagnosed with atrial fibrillation. Please find

More information

Anticoagulation in a nurse-led AF-Clinic

Anticoagulation in a nurse-led AF-Clinic Anticoagulation in a nurse-led AF-Clinic Dr. Jeroen ML Hendriks Maastricht University Medical Centre The Netherlands Department of Cardiology Linköping University - Sweden Department of Medical and Health

More information

Rising to the challenge: Delivering QIPP by preventing AF-related stroke. Foreword

Rising to the challenge: Delivering QIPP by preventing AF-related stroke. Foreword 2 Foreword Rising to the challenge: Delivering QIPP by preventing AF-related stroke Opportunities to improve the quality, safety and cost-effectiveness of NHS services that reduce the risk of stroke in

More information

What is prescribing? Proposal. Non-Medical Prescribing. 4 Domains of Prescribing. Mapping the 4 Domains of Prescribing.

What is prescribing? Proposal. Non-Medical Prescribing. 4 Domains of Prescribing. Mapping the 4 Domains of Prescribing. Non-Medical Charles Mitchell What is prescribing? Director CSEP, University of Queensland Senior Medical Advisor, MSQ, QH Proposal should be considered in a similar way to procedures Where a combination

More information

Improving Safety Practices Anticoagulation Therapy

Improving Safety Practices Anticoagulation Therapy Improving Safety Practices Anticoagulation Therapy Katie Cinnamon, PharmD, BCPS Clinical Pharmacist Genesis Medical Center - Davenport Objectives Review background information on medication errors and

More information

Integrated heart failure service working across the hospital and the community

Integrated heart failure service working across the hospital and the community Integrated heart failure service working across the hospital and the community Lynne Ruddick Professional Lead (South) British Heart Foundation 31st October 2017 Heart Failure is an epidemic. NICE has

More information

INR Self Testing. Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA

INR Self Testing. Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA P A T I E N T I N F O R M A T I O N G U I D E INR Self Testing Stephan Moll, MD Department of Medicine HEMOPHILIA AND THROMBOSIS CENTER UNIVERSITY OF NORTH CAROLINA A Summary INR home testing devices are

More information

POWYS TEACHING HEALTH BOARD PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE

POWYS TEACHING HEALTH BOARD PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE POWYS TEACHING HEALTH BOARD Meeting 04/12/12 Present: PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE Minutes of the meeting held on Thursday, 06 September 2012 at 09.30am in Training Room 1, Bronllys

More information

A Comparative Effectiveness Trial Warfarin versus Direct Oral Anti- Coagulants. Thomas L. Ortel, M.D., Ph.D. 2 December 2016

A Comparative Effectiveness Trial Warfarin versus Direct Oral Anti- Coagulants. Thomas L. Ortel, M.D., Ph.D. 2 December 2016 A Comparative Effectiveness Trial Warfarin versus Direct Oral Anti- Coagulants Thomas L. Ortel, M.D., Ph.D. 2 December 2016 Comparative Effectiveness Research The IOM Definition of CER: Comparative effectiveness

More information

Protocol for Patients on oral Anticoagulants who wish to perform INR self testing. Anticoagulation service Bolton NHS Foundation Trust. April 2017.

Protocol for Patients on oral Anticoagulants who wish to perform INR self testing. Anticoagulation service Bolton NHS Foundation Trust. April 2017. Protocol for Patients on oral Anticoagulants who Anticoagulation service Bolton NHS Foundation Trust April 2017. Document Control Document Ref No. ANTICO05 Title of document Protocol for Patient s on oral

More information

Delivering the QIPP programme: making existing services improve patient outcomes

Delivering the QIPP programme: making existing services improve patient outcomes Delivering the QIPP programme: making existing services improve patient outcomes Produced by Glyn Davies MP, Chair All-Party Parliamentary Group on AF in association with the Atrial Fibrillation Association

More information

By Harry Crank Coordinator

By Harry Crank Coordinator 1 Integrating IT systems to optimise patient care pathways By Harry Crank Coordinator 3 5 Where are we? Area of where we cover Brief overview of our Service 4600+ patients Pharmacists, Nurses, Phlebotomists

More information

Principles of Shared Care Protocols

Principles of Shared Care Protocols Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the

More information

Survey into the diagnosis, management and treatment of patients with Atrial Fibrillation

Survey into the diagnosis, management and treatment of patients with Atrial Fibrillation CHRIS RUANE MP, PRIMARY CARE CARDIOVASCULAR SOCIETY and ATRIAL FIBRILLATION ASSOCIATION FREEDOM OF INFORMATION REQUEST Survey into the diagnosis, management and treatment of patients with Atrial Fibrillation

More information

Sheffield Teaching Hospitals: Pulmonary Hypertension. Information for Medical Staff 31/03/2014. Local guidelines

Sheffield Teaching Hospitals: Pulmonary Hypertension. Information for Medical Staff 31/03/2014. Local guidelines Sheffield Teaching Hospitals: Pulmonary Hypertension Information for Medical Staff 31/03/2014 Local guidelines Diagnostic pathway - page 2 Iloprost dosing chart and conversion table - page 3-4 Hickman

More information

Comparison of Anticoagulation Clinic Patient Outcomes With Outcomes From Traditional Care in a Family Medicine Clinic

Comparison of Anticoagulation Clinic Patient Outcomes With Outcomes From Traditional Care in a Family Medicine Clinic Comparison of Anticoagulation Clinic Patient Outcomes With Outcomes From Traditional Care in a Family Medicine Clinic Marvin A. Chamberlain, RPh, MS, Nannette A. Sageser, Pharm D, and David Ruiz, MD Background:

More information

Lars Wallentin, Salim Yusuf, Michael Ezekowitz, Sean Young, Janice Pogue, Stuart Connolly, for the RELY Investigators

Lars Wallentin, Salim Yusuf, Michael Ezekowitz, Sean Young, Janice Pogue, Stuart Connolly, for the RELY Investigators Efficacy and Safety of Dabigatran Compared to at Different Levels of INR Control for Stroke Prevention in 18,113 patients with Atrial Fibrillation in the RE-LY Trial Lars Wallentin, Salim Yusuf, Michael

More information

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres

Community DVT Service. Phase 3: Anticoagulation at DVT Treatment Centres Community DVT Service Quick Reference Guide Phase - Anticoagulation Phase : Anticoagulation at DVT Treatment Centres If a Patient has had a positive Ultrasound Scan they attend one of the DVT Treatment

More information

Out of tariff high cost drug / technology business case template

Out of tariff high cost drug / technology business case template Out of tariff high cost drug / technology business case template Out of tariff high cost drug / technology business case template Please read all the criteria before completing any of the template For

More information

How Pharmacies are supporting the move from Secondary to Primary Care. Peter Bainbridge, Director of Pharmacy,

How Pharmacies are supporting the move from Secondary to Primary Care. Peter Bainbridge, Director of Pharmacy, How Pharmacies are supporting the move from Secondary to Primary Care Peter Bainbridge, Director of Pharmacy, Alliance Boots Present in over 25 countries Over 116,000 employees 3,330 Health and Beauty

More information

Integrating Pharmacological Therapies across the Curriculum

Integrating Pharmacological Therapies across the Curriculum Integrating Pharmacological Therapies across the Curriculum Implementation of ATI's Pharmacology Made Easy and Dosage Calculations to Improve Student Learning Outcomes. Laurie Fontenot, MSN, RN, Janet

More information

Reducing Medication Errors: National Update

Reducing Medication Errors: National Update Reducing Medication Errors: National Update Ahmed Ameer Medication Safety Officer Ahmed.Ameer@NHS.net Safer Medication Practice & Medical Devices Team 27 th January 2015 Agenda 1. Development of the National

More information

INCLUSION CRITERIA. REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as "Stroke Service" in Cerner.

INCLUSION CRITERIA. REMINDER: Please ensure all stroke and TIA patients admitted to hospital are designated as Stroke Service in Cerner. ACUTE STROKE CLINICAL PATHWAY The clinical pathway is based on evidence informed practice and is designed to promote timely treatment, enhance quality of care, optimize patient outcomes and support effective

More information

ANTICOAGULATION MONITORING SERVICE. Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service

ANTICOAGULATION MONITORING SERVICE. Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service ANTICOAGULATION MONITORING SERVICE Standard Operating Procedure For the provision of a Level 3, 4 and 5 Anticoagulation Service Version: Date at ET/PEC: September 2008 Date ratified at Board: Name and

More information

HEALTHCARE PIONEERS SHOWCASING BEST PRACTICE IN AF

HEALTHCARE PIONEERS SHOWCASING BEST PRACTICE IN AF ALL-PARTY PARLIAMENTARY GROUP HEALTHCARE PIONEERS SHOWCASING BEST PRACTICE IN AF Supported by the All-Party Parliamentary Group on Atrial Fibrillation (APGAF) April 2015 Registered Charity No. 1122442

More information

Best Practice Tariff: Early Inflammatory Arthritis

Best Practice Tariff: Early Inflammatory Arthritis Best Practice Tariff: Early Inflammatory Arthritis Dear colleague, The Payment by Results team at the Department of Health has recently issued the 2013-14 road test package for comment. The purpose of

More information

Shared Care Agreements for Medicines

Shared Care Agreements for Medicines Shared Care Agreements for Medicines Author: Scott Garden, Chief Pharmacist, Acute Services Version: 1.0 Authorised by: NHS Fife Area Drug and Therapeutics Committee Date of Authorisation: Review Date:

More information

Schedule C1. Community Pharmacy Anti-Coagulation Management Services

Schedule C1. Community Pharmacy Anti-Coagulation Management Services Schedule C1 Community Pharmacy Anti-Coagulation Management Services 1. Definition This service specification relates to the anticoagulation management of Service Users on warfarin by an accredited community

More information

HASTE-Network In Guildford and Surrey. Background. Arrhythmia Screening in Primary care to reduce Stroke. HASTENinGS 2013

HASTE-Network In Guildford and Surrey. Background. Arrhythmia Screening in Primary care to reduce Stroke. HASTENinGS 2013 HASTE-Network In Guildford and Surrey Arrhythmia Screening in Primary care to reduce Stroke Background Atrial Fibrillation is a very common heart condition which causes 15-20% of all Stroke. Its incidence

More information

Indian River Medical Center Policy #: 10.1 Policies and Procedures

Indian River Medical Center Policy #: 10.1 Policies and Procedures Indian River Medical Center Policy #: 10.1 Policies and Procedures Title: ANTICOAGULATION CLINIC Effective Date: Chapter: Pharmacy Reviewed Date: Responsible Person: Director of Pharmacy Revised Date:

More information

Atrial Fibrillation in Primary Care

Atrial Fibrillation in Primary Care NHS NHS Improvement CANCER DIAGNOSTICS HEART STROKE Heart Improvement Atrial Fibrillation in Primary Care National Priority Project Atrial Fibrillation in Primary Care is a national priority project of

More information

Organizational Initiative

Organizational Initiative Organizational Initiative Prevention and Treatment of Venous Thromboembolism (VTE) Nursing s Role Donna Grochow MSN, RN May 2012 1 Agenda Organizational Initiative: Why Now? Review of current performance

More information

After reading this learning module, the nurse should be able to:

After reading this learning module, the nurse should be able to: After reading this learning module, the nurse should be able to: Identify the VTE dashboard and understand how to initiate it Identify the requirements of the VTE Core Measure and the nurse s responsibilities

More information

PQRS Success in 2015:

PQRS Success in 2015: PQRS Success in 2015: The Effects of Applicability Validation (MAV) on s Selection for Hospitalists Why is Applicability Validation (MAV) important? CMS requires all eligible professionals (EPs) successfully

More information

SIMPLE SOLUTIONS. BIG IMPACT.

SIMPLE SOLUTIONS. BIG IMPACT. SIMPLE SOLUTIONS. BIG IMPACT. SIMPLE SOLUTIONS. BIG IMPACT. QUALITY IMPROVEMENT FOR INSTITUTIONS combines the American College of Cardiology s (ACC) proven quality improvement service solutions and its

More information

Data Acquisition & Transmission

Data Acquisition & Transmission Using Clinically-Enhanced Claims Data to Guide Treatment of Acute Heart Failure An AHRQ Grant to MHA Data Acquisition & Transmission Pharmacy Data Overview of Data Acquisition Strategy Establish data specifications

More information

Setting up an Anticoagulation Clinic in Primary Care. Contents

Setting up an Anticoagulation Clinic in Primary Care. Contents Setting up an Anticoagulation Clinic in Primary Care This paper aims to outline the decisions and practical steps needed to set up and run a successful anticoagulation clinic in a primary care setting.

More information

Standards for insertion, follow up and explant of implantable loop recorders [ILRs] by non-medical staff

Standards for insertion, follow up and explant of implantable loop recorders [ILRs] by non-medical staff Standards for insertion, follow up and explant of implantable loop recorders [ILRs] by non-medical staff August 2018 First edition 1. Introduction This document has been produced by a group of arrhythmia

More information

Inpatient Anticoagulation Management Services to Improve Transitions of Care

Inpatient Anticoagulation Management Services to Improve Transitions of Care Inpatient Anticoagulation Management Services to Improve Transitions of Care Andrea Resseguie PharmD, RPh, CACP Advanced Practice Clinical Specialist Anticoagulation Management Service Learning Objectives

More information

Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin

Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin Protocol Number: 7 Protocol Title: Ambulatory Initiation and Management of Warfarin for Adults Protocol Applies To: UW Health Clinics: all adult outpatients with an active order for warfarin Target Patient

More information

Overview and History of AMS. Lynn Oertel, MS, ANP, CACP Clinical Nurse Specialist Anticoagulation Management Service MESAC - November 18, 2014

Overview and History of AMS. Lynn Oertel, MS, ANP, CACP Clinical Nurse Specialist Anticoagulation Management Service MESAC - November 18, 2014 Overview and History of AMS Lynn Oertel, MS, ANP, CACP Clinical Nurse Specialist Anticoagulation Management Service MESAC - November 18, 2014 Anticoagulation Management Service (AMS) Location POB, 275

More information

The Joint Commission Medication Management Update for 2010

The Joint Commission Medication Management Update for 2010 Learning Objectives The Joint Commission Medication Management Update for 2010 U.S. Army Medical Command Fort Sam Houston, TX Describe most recent changes in The Joint Commission (TJC) Accreditation Program

More information

Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE

Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE EQUALITY IMPACT The Trust strives to ensure equality and opportunity for all, both as a major employer and as a provider of health care. This policy

More information

Preventing Heart Attacks and Strokes The Size of the Prize

Preventing Heart Attacks and Strokes The Size of the Prize Preventing Heart Attacks and Strokes The Size of the Prize Dr Matt Kearney General Practitioner and National Clinical Director for CVD Prevention NHS England and Public Health England The NHS needs a radical

More information

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse

More information